efc15-602_fmsc13da.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
| SUNOPTA INC. |
| (Name of Issuer) |
| Common Shares, no par value |
| (Title of Class of Securities) |
Supriya Kapoor
2 Bloor Street East, Suite 3000
Toronto, Ontario M4W 1A8
(647) 724-8900
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
August 12, 2015
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
CUSIP No.: 8676EP108
|
|
Page 2 of 7 Pages |
|
1.
|
Names of Reporting Persons.
WEST FACE CAPITAL INC.
|
|
2.
|
Check the Appropriate Box if a Member of a Group
(a) [ ]
(b) [ ]
|
|
3.
|
SEC Use Only
|
|
4.
|
Citizenship or Place of Organization
|
|
Number of
Shares
Beneficially
Owned by Each Reporting
Person With
|
5.
|
Sole Voting Power
|
None
|
|
6.
|
Shared Voting Power
|
4,169,700
|
|
7.
|
Sole Dispositive Power
|
None
|
|
8.
|
Shared Dispositive Power
|
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ]
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
6.1%
|
|
12.
|
Type of Reporting Person:
CO, FI
|
|
CUSIP No.: 8676EP108
|
|
Page 3 of 7 Pages |
|
1.
|
Names of Reporting Persons.
GREGORY A. BOLAND
|
|
2.
|
Check the Appropriate Box if a Member of a Group
(a) [ ]
(b) [ ]
|
|
3.
|
SEC Use Only
|
|
4.
|
Citizenship or Place of Organization
Canada
|
|
Number of
Shares
Beneficially
Owned by Each Reporting
Person With
|
5.
|
Sole Voting Power
|
None
|
|
6.
|
Shared Voting Power
|
|
|
7.
|
Sole Dispositive Power
|
None
|
|
8.
|
Shared Dispositive Power
|
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ]
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
6.1%
|
|
12.
|
Type of Reporting Person:
IN, HC
|
Page 4 of 7 Pages
|
Item 1.
|
Security and Issuer
|
This Amendment No. 5 to Schedule 13D is being filed by West Face Capital Inc. (“West Face”) and Gregory A. Boland (“Mr. Boland”) (collectively, the “Reporting Persons”), pursuant to §240.13d-2(a), to amend the Schedule 13D filed on February 23, 2012 (“Initial Schedule 13D”) as amended by Amendment No. 1 filed on May 18, 2012, Amendment No. 2 filed on August 15, 2013, Amendment No. 3 filed on August 28, 2014 and Amendment No. 4 filed on September 8, 2014 (Amendment No. 1, Amendment No. 2, Amendment No. 3 and Amendment No. 4, together with the Initial Schedule 13D, the "Amended Schedule 13D") relating to the Common Shares, no par value (the “Shares”), of SunOpta Inc. (the “Issuer”), whose principal executive offices are located at 2838 Bovaird Drive West, Brampton, Ontario L7A 0H2, Canada. Except as set forth below, all Items of the Amended Schedule 13D remain unchanged. All capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Amended Schedule 13D.
|
Item 4.
|
Purpose of Transaction
|
Item 4 of the Amended Schedule 13D is hereby amended and supplemented as follows:
As disclosed in the Issuer’s definitive proxy statement on Schedule 14A filed on April 17, 2015, Peter L. Fraser, a partner and co-Chief Investment Officer of West Face, did not stand for re-election to the Issuer’s board of directors at the Issuer’s Annual Meeting of Shareholders, held on Thursday, May 28, 2015. Accordingly, as of May 28, 2015, Mr. Fraser is no longer a member of the Issuer’s board of directors.
|
Item 5.
|
Interest in Securities of the Issuer
|
Item 5 of the Amended Schedule 13D is hereby amended and restated in its entirety as follows:
(a, b) The aggregate number of Shares and the percentage of total outstanding Shares beneficially owned by the Reporting Persons as of August 14, 2015 is set forth below:
|
Reporting Person
|
Number of Shares
Beneficially Owned*
|
Percentage of Outstanding
Shares
|
Number of Outstanding
Shares**
|
|
West Face
|
4,169,700
|
6.1%
|
68,628,783
|
|
Mr. Boland
|
4,169,700
|
6.1%
|
68,628,783
|
* The beneficial ownership for which each figure is provided in this column is the shared, not sole, power to vote or to direct the vote, and the shared, not sole, power to dispose or to direct the disposition of the Shares.
** This figure is based upon information in the Issuer’s quarterly report on Form 10-Q, filed August 13, 2015, indicating that, as of August 7, 2015, there were 68,628,783 Shares outstanding.
(c) On August 12, 2015, the Reporting Persons sold 205,000 Shares at a sale price of $9.90 per Share. The foregoing transaction was effected for the account of West Face Long Term Opportunities Global Master L.P (“WFGM”), in the open market through a broker. Other than the foregoing, there were no transactions in the Shares by the Reporting Persons in the past 60 days.
(d) WFGM is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5 percent of the class of Shares covered by this statement that may be deemed to be beneficially owned by the Reporting Persons.
(e) This Item 5(e) is not applicable.
|
Item 7.
|
Material to be Filed as Exhibits.
|
Exhibit A: Joint Filing Agreement
Exhibit B: Power of Attorney
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| |
WEST FACE CAPITAL INC. |
|
| |
|
|
| |
|
|
|
|
By:
|
/s/ Supriya Kapoor |
|
| |
Name: |
Supriya Kapoor |
|
| |
Title: |
Attorney-in-fact for Gregory A. Boland,
President and Chief Executive Officer of
West Face Capital Inc.
|
|
| |
|
|
|
| |
GREGORY A. BOLAND
|
|
| |
|
|
| |
|
|
|
|
By:
|
/s/ Supriya Kapoor |
|
| |
Name: |
Supriya Kapoor |
|
| |
Title: |
Attorney-in-fact for Gregory A. Boland
|
|
| |
|
|
|
August 14, 2015
Attention: Intentional misstatements or omissions of act constitute federal violations (see 18 U.S.C. 1001).
SCHEDULE 13D
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Shares of SunOpta Inc., dated as of August 14, 2015 is, and any amendments thereto (including amendments on Schedule 13G) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
| |
WEST FACE CAPITAL INC. |
|
| |
|
|
| |
|
|
|
|
By:
|
/s/ Supriya Kapoor |
|
| |
Name: |
Supriya Kapoor |
|
| |
Title: |
Attorney-in-fact for Gregory A. Boland,
President and Chief Executive Officer of
West Face Capital Inc.
|
|
| |
|
|
|
| |
GREGORY A. BOLAND
|
|
| |
|
|
| |
|
|
|
|
By:
|
/s/ Supriya Kapoor |
|
| |
Name: |
Supriya Kapoor |
|
| |
Title: |
Attorney-in-fact for Gregory A. Boland
|
|
| |
|
|
|
August 14, 2015
EXHIBIT B
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENT, that I, Gregory A. Boland, hereby make, constitute and appoint each of John Maynard, Stephen Miller, Supriya Kapoor and Philip de L. Panet, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as President and Chief Executive Officer of West Face Capital Inc., a Canadian company, and a director of West Face (Cayman 2) Inc., a Cayman Islands company, and each of the affiliates or entities advised or controlled by me, West Face Capital Inc., or West Face (Cayman 2) Inc., all documents, certificates, instruments, statements, filings and agreements (“documents”) to be filed with or delivered to any foreign or domestic governmental or regulatory body or required or requested by any other person or entity pursuant to any legal or regulatory requirement relating to the acquisition, ownership, management or disposition of securities, futures contracts or other investments, and any other documents relating or ancillary thereto, including, without limitation, all documents relating to filings with the United States Securities and Exchange Commission (the “SEC”) pursuant to the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (the “Act”), and the rules and regulations promulgated thereunder, including, without limitation: (1) all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act, including, without limitation: (a) any acquisition statements on Schedule 13D or Schedule 13G and any amendments thereto, (b) any joint filing agreements pursuant to Rule 13d-1(k), and (c) any initial statements of, or statements of changes in, beneficial ownership of securities on Form 3, Form 4 or Form 5 and (2) any information statements on Form 13F required to be filed with the SEC pursuant to Section 13(f) of the Act.
All past acts of this attorney-in-fact in furtherance of the foregoing are hereby ratified and confirmed.
This Power of Attorney shall remain in effect until revoked, in writing, by the undersigned.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney, this 20th day of April 2015.
| |
|
|
|
|
|
|
/s/ Gregory A. Boland |
|
| |
|
Gregory A. Boland
|
|